MedTrace Logo

Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer

NCT03125460 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 424

Last updated 2020-02-07

No results posted yet for this study

Summary

The objective of this study is to establish the performance characteristics of an assay that detects the recurrence of bladder cancer in patients previously diagnosed with bladder cancer. The study is conducted at locations within and outside of the United States. Testing is performed on urine specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.

Conditions

Interventions

DEVICE

Xpert Bladder Cancer Monitor

in vitro diagnostic test for the recurrence of bladder cancer in patients that have been previously diagnosed with bladder cancer

Sponsors & Collaborators

  • Cepheid

    lead INDUSTRY

Eligibility

Min Age
40 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-02-28
Completion
2019-05-31

Countries

  • United States
  • Canada
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03125460 on ClinicalTrials.gov